{"SLR NAME":"Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis","References":[{"title1":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID?19","References":[{"title2":"Coronavirus disease 2019 (COVID-19) Situation Report-23","References":[]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","References":[{"title3":"XINHUANET News Report"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Coronaviruses-drug discovery and therapeutic options"},{"title3":"Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"}]},{"title2":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"MERS, SARS and other coronaviruses as causes of pneumonia","References":[{"title3":"Coronavirus pathogenesis"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"  . Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fact Sheet [Accessed 28 Aug 2017.] Available from URL: http://www.who.int/mediacentre/factsheets/mers-cov/en/."},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Evidence supporting a zoonotic origin of human coronavirus strain NL63"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Middle East Respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 Outbreak in Korea"},{"title3":"Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and molecular epidemiology of coronavirus-HKU1-associated community-acquired pneumonia"},{"title3":"Severe acute respiratory syndrome (SARS): a year in review"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014"},{"title3":"Outbreaks of Middle East respiratory syndrome in two hospitals initiated by a single patient in Daejeon, South Korea"},{"title3":"First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong"},{"title3":"Epidemiology of coronavirus-associated respiratory tract infections and the role of rapid diagnostic tests: a prospective study"},{"title3":"Prevalence and molecular epidemiology of human coronavirus HKU1 in patients with acute respiratory illness"},{"title3":"Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation"},{"title3":"Community-acquired pneumonia requiring hospitalization among U.S. adults"},{"title3":"Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China"},{"title3":"Coronavirus spike proteins in viral entry and pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the Middle East respiratory syndrome"},{"title3":"Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels"},{"title3":"The multifunctional or moonlighting protein CD26/DPPIV"},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation"},{"title3":"Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"SARS-associated coronavirus replication in cell lines"},{"title3":"  . Clinical Management of Severe Acute Respiratory Infection When Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection Is Suspected [Accessed 28 Aug 2017.] Available from URl: http://www.who.int/csr/disease/coronavirus_infections/case-management-ipc/en."},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic"},{"title3":"SARS: prognosis, outcome and sequelae"},{"title3":"Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"mRNA cap-1 methyltransferase in the SARS genome"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Passive transfer of a germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus infection"},{"title3":"Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus"},{"title3":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"SARS and MERS: recent insights into emerging coronaviruses","References":[{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"WHO. Summary of probably SARS cases with onset of illness from 1 November 2002 to 31 July 2003. WHO, http://www.who.int/csr/sars/country/table2004_04_21/en/ (2004)."},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Patient with new strain of coronavirus is treated in intensive care at London hospital"},{"title3":"Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res. Perspect.6, 269-278 (2015)."},{"title3":"WHO. Coronavirus infections: disease outbreak news. WHO, http://www.who.int/csr/don/26-april-2016-mers-saudi-arabia/en/ (2016)."},{"title3":"Nidovirus transcription: how to make sense...?"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"Infidelity of SARS-CoV nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Review of bats and SARS"},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS"},{"title3":"Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"MERS coronavirus in dromedary camel herd, Saudi Arabia"},{"title3":"Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014"},{"title3":"MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997"},{"title3":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Biomarkers in acute respiratory distress syndrome"},{"title3":"The mercurial nature of neutrophils: still an enigma in ARDS?"},{"title3":"SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the Collaborative Cross"},{"title3":"Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"In vitro reconstitution of SARS-coronavirus mRNA cap methylation"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-O-methyltransferase activity"},{"title3":"Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments"},{"title3":"The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity"},{"title3":"Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression"},{"title3":"SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage"},{"title3":"A two-pronged strategy to suppress host protein synthesis by SARS coronavirus nsp1 protein"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Middle East respiratory syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the nucleus while sparing mRNAs of cytoplasmic origin"},{"title3":"Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"MAVS-mediated apoptosis and its inhibition by viral proteins"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Mechanisms of action of ribavirin against distinct viruses"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Clinical analysis of the first patient with imported Middle East respiratory syndrome in China"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts"},{"title3":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a non-human primate model of common marmoset"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Middle East respiratory syndrome-coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"Kim, U. J., Won, E. J., Kee, S. J., Jung, S. I. &amp; Jang, H. C. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report. Antivir. Ther.10.3851/IMP3002 (2015)."},{"title3":"Rhee, J. Y., Hong, G. &amp; Ryu, K. M. Clinical implications of five cases of Middle East respiratory syndrome coronavirus infection in South Korea Outbreak. Jpn J. Infect. Dis.10.7883/yoken.JJID.2015.445 (2016)."},{"title3":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design"},{"title3":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus"},{"title3":"Ligand-induced dimerization of Middle East respiratory syndrome (MERS) coronavirus nsp5 protease (3CLpro): implications for nsp5 regulation and the development of antivirals"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"International Severe Acute Respiratory &amp; Emerging Infection Consortium. Treatment of MERS-CoV: decision support tool. International Severe Acute Respiratory &amp; Emerging Infection Consortium, https://isaric.tghn.org/site_media/media/articles/Decision_Support_Document_v1_1_20130729.pdf (updated 29 July 2013)."},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein"},{"title3":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Prophylaxis with a MERS-CoV-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012"},{"title3":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody"},{"title3":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"The role of C5a in acute lung injury induced by highly pathogenic viral infections"},{"title3":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus"},{"title3":"A decade after SARS: strategies for controlling emerging coronaviruses"},{"title3":"SARS vaccines: where are we?"},{"title3":"Middle East respiratory syndrome: current status and future prospects for vaccine development"},{"title3":"Evaluation of candidate vaccine approaches for MERS-CoV"},{"title3":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge"},{"title3":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates"},{"title3":"Immune efficacy of first and repeat trivalent influenza vaccine in healthy subjects and hemodialysis patients"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014"},{"title3":"Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"SARS-like WIV1-CoV poised for human emergence"}]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]}]},{"title1":"Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China","References":[{"title2":"Critical care management of adults with community-acquired severe respiratory viral infection","References":[{"title3":"Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia"},{"title3":"The role of human metapneumovirus in the critically ill adult patient"},{"title3":"Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options"},{"title3":"Hanfelt-Goade D, Maimon N, Nimer A, et al A phase 2b, randomized, double-blind, placebo-controlled trial of presatovir (GS-5806), a novel oral rsv fusion inhibitor, for the treatment of respiratory syncytial virus (RSV) in hospitalized adults American Thoracic Society 2018 international conference, San Diego, 2018: abstract A4457"},{"title3":"Efficacy and safety of nitazoxanide in addition to standard of care for the treatment of severe acute respiratory illness"},{"title3":"Advances in respiratory virus therapeutics:a meeting report from the 6th isirv Antiviral Group conference"},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data"},{"title3":"Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry"},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09"},{"title3":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa"},{"title3":"High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients"},{"title3":"A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections"},{"title3":"Comparison of high-dose versus standard dose oseltamivir in critically ill patients with influenza"},{"title3":"Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial"},{"title3":"Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza"},{"title3":"Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia"},{"title3":"Oseltamivir resistance in severe influenza A(H1N1)pdm09 pneumonia and acute respiratory distress syndrome: a French multicenter observational cohort study"},{"title3":"Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial"},{"title3":"Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients"},{"title3":"Influenza virus polymerase inhibitors in clinical development"},{"title3":"LB16. Phase 3 trial of baloxavir marboxil in high-risk influenza patients (CAPSTONE-2 study)"},{"title3":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial"},{"title3":"Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia"},{"title3":"Macrolides in critically ill patients with Middle East Respiratory Syndrome"},{"title3":"Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection"},{"title3":"The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness"},{"title3":"The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome"},{"title3":"Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection"},{"title3":"Hung IF, Wang To KK, Chan J, Chan KH, Yuen KY. ECCMID 2019. O0815 Treatment of severe influenza A infection with celecoxib. https://www.escmid.org. Accessed 14 Sep 2019"},{"title3":"Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration"},{"title3":"Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model"},{"title3":"Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure"},{"title3":"Simvastatin in the acute respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial"},{"title3":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection"},{"title3":"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial"},{"title3":"Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial"},{"title3":"Effect of vitamin c infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI Randomized clinical trial"},{"title3":"Influenza coinfection: be(a)ware of invasive aspergillosis"},{"title3":"Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Risk factors for noninvasive ventilation failure in critically ill subjects with confirmed influenza infection"},{"title3":"Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome"},{"title3":"Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation"},{"title3":"Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome"},{"title3":"Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial"},{"title3":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure"},{"title3":"High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v"},{"title3":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis"},{"title3":"Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial I, Cavalcanti AB, Suzumura EA, Laranjeira LN, Paisani DM, Damiani LP, Guimaraes HP, Romano ER, Regenga MM, Taniguchi LNT, Teixeira C, Pinheiro de Oliveira R, Machado FR, Diaz-Quijano FA, Filho MSA, Maia IS, Caser EB, Filho WO, Borges MC, Martins PA, Matsui M, Ospina-Tascon GA, Giancursi TS, Giraldo-Ramirez ND, Vieira SRR, Assef M, Hasan MS, Szczeklik W, Rios F, Amato MBP, Berwanger O, Ribeiro de Carvalho CR, (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on Mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318:1335-1345"},{"title3":"Experience with high frequency oscillation ventilation during the 2009 H1N1 influenza pandemic in Australia and New Zealand"},{"title3":"High-frequency oscillation in early acute respiratory distress syndrome"},{"title3":"High-frequency oscillation for acute respiratory distress syndrome"},{"title3":"Severity of hypoxemia and effect of high-frequency oscillatory ventilation in acute respiratory distress syndrome"},{"title3":"Prone positioning in severe acute respiratory distress syndrome"},{"title3":"A multicenter retrospective review of prone position ventilation (PPV) in treatment of severe human H7N9 avian flu"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc bayesian analysis of a randomized clinical trial"},{"title3":"Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1)"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"},{"title3":"National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Jr., Hite RD, Harabin AL, (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564-2575"},{"title3":"Right and left heart failure in severe H1N1 influenza A infection"},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection"},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection"},{"title3":"Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care"},{"title3":"Successful treatment of novel H1N1 influenza related fulminant myocarditis with extracorporeal life support"},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review"},{"title3":"N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial"},{"title3":"Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial"},{"title3":"A cluster randomised trial of cloth masks compared with medical masks in healthcare workers"},{"title3":"Situations leading to reduced effectiveness of current hand hygiene against infectious mucus from influenza virus-infected patients"},{"title3":"WHO public health research agenda for influenza. https://www.who.int/influenza/resources/research/en/. Last accessed Jan 4-2020"}]},{"title2":"Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome","References":[]},{"title2":"Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov","References":[]},{"title2":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"CT Imaging and Differential Diagnosis of COVID-19","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"Radiographic and CT features of viral pneumonia"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"Spectrum of imaging findings in pulmonary infections. Part 1: Bacterial and viral"},{"title3":"The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm"},{"title3":"Community-acquired pneumonia caused by Mycoplasma pneumoniae: how physical and radiological examination contribute to successful diagnosis"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Viral pneumonia requiring differentiation from acute and progressive diffuse interstitial lung diseases"},{"title3":"The fight against the 2019-nCoV outbreak: an arduous march has just begun"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"}]},{"title2":"General Office of National Health Commission, General Office of National Administration of Traditional Chinese Medicine. Diagnostic and treatment protocol for Novel Coronavirus Pneumonia (Trial version 5) [EB/OL]. (2020-02-04) [2020-02-15]. http://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474791.htm.","References":[]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019nCoV epidemic threat of novel coronaviruses to global health  the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (SARS-CoV-2), December 2019 to January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"The latest situation of new coronavirus pneumonia as of 24:00 on February"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (SARS-CoV-2)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathogenicity and transmissibility of SARS-CoV-2-A quick overview and comparison with other emerging viruses"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Notice on issuing a new coronavirus infected pneumonia diagnosis and treatment plan (Trial Version 5)"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"30 January 2020 pneumonia epidemic situation of C SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"4 February 2020 pneumonia epidemic situation of SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus"},{"title3":"CT imaging features of 2019 novel coronavirus (SARS-CoV-2)"},{"title3":"Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease"},{"title3":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Detection of Covid-19 in children in early January 2020 in Wuhan, China"},{"title3":"National Health Commission. Notice on issuing a nw coronary virus pneumonia diagnosis and treatment plan (Trial Version 7)"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Isolation and Characterization of 2019-nCoV-like Coronavirus from Malayan","References":[]},{"title2":"A question of self-preservation: immunopathology in influenza virus infection","References":[]},{"title2":"Factors associated with psychosis among patients with severe acute respiratory syndrome a case-control study","References":[]},{"title2":"Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Structural basis for lipid binding and function by an evolutionarily conserved protein, serum amyloid A"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"'Hints' in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death"},{"title3":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"C-reactive protein and inflammation: conformational changes affect function"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"A novel coronavirus from patients with pneumonia in China"}]},{"title2":"Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence","References":[]},{"title2":"Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR","References":[]},{"title2":"Viral Metagenomics Revealed Sendai Virus and Coronavirus Infection of Malayan Pangolins (Manis javanica)","References":[{"title3":"The phylogeny of living and extinct pangolins (mammalia, pholidota) and associated taxa: A morphology based analysis"},{"title3":"Immunohistochemical demonstration of keratins in the epidermal layers of the Malayan pangolin (Manis javanica), with remarks on the evolution of the integumental scale armour"},{"title3":"Complete Genome Sequence of Parainfluenza Virus 5 (PIV5) from a Sunda Pangolin (Manis javanica) in China"},{"title3":"Virome Analysis for Identification of Novel Mammalian Viruses in Bat Species from Chinese Provinces"},{"title3":"Faecal virome of cats in an animal shelter"},{"title3":"Exploring the virome of diseased horses"},{"title3":"A Metagenomics and Case-Control Study to Identify Viruses Associated with Bovine Respiratory Disease"},{"title3":"Faecal virome of healthy chickens reveals a large diversity of the eukaryote viral community, including novel circular ssDNA viruses"},{"title3":"Characterisation of the virome of tonsils from conventional pigs and from specific pathogen-free pigs"},{"title3":"Virome Diversity Correlates with Intestinal Microbiome Diversity in Adult Monozygotic Twins"},{"title3":"Further Defining the Human Virome using NGS: Identification of Redondoviridae"},{"title3":"Metagenomics for the discovery of novel human viruses"},{"title3":"Viral pathogen discovery"},{"title3":"Metagenomics and novel gene discovery: Promise and potential for novel therapeutics"},{"title3":"Diagnostic metagenomics: Potential applications to bacterial, viral and parasitic infections"},{"title3":"Metagenomics: Facts and artifacts, and computational challenges"},{"title3":"New tools for discovering and characterizing microbial diversity"},{"title3":"Detection of viruses in abalone tissue using metagenomics technology"},{"title3":"SOAPnuke: A MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"MEGAHIT v1.0: A fast and scalable metagenome assembler driven by advanced methodologies and community practices"},{"title3":"Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences"},{"title3":"MAFFT multiple sequence alignment software version 7: Improvements in performance and usability"},{"title3":"W-IQ-TREE: A fast online phylogenetic tool for maximum likelihood analysis"},{"title3":"Diversity and Evolution of Viral Pathogen Community in Cave Nectar Bats (Eonycteris spelaea)"},{"title3":"Virome analysis for identification of novel mammalian viruses in bats from Southeast China"},{"title3":"Fruit bats as reservoirs of Ebola virus"},{"title3":"Bats: Important reservoir hosts of emerging viruses"},{"title3":"Review of bats and SARS"},{"title3":"Studies of reservoir hosts for Marburg virus"},{"title3":"Novel Astroviruses in Insectivorous Bats"},{"title3":"Host Range, Prevalence, and Genetic Diversity of Adenoviruses in Bats"},{"title3":"Bats as a continuing source of emerging infections in humans"},{"title3":"Novel lyssavirus in Natterer's bat, Germany"},{"title3":"Complete Genome Analysis of Three Novel Picornaviruses from Diverse Bat Species"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Identifying hendra virus diversity in pteropid bats"},{"title3":"A comparison of bats and rodents as reservoirs of zoonotic viruses: Are bats special?"},{"title3":"The Fecal Virome of Pigs on a High-Density Farm"},{"title3":"Diversity of viruses detected by deep sequencing in pigs from a common background"},{"title3":"Metagenomic analysis demonstrates the diversity of the fecal virome in asymptomatic pigs in East Africa"},{"title3":"Sendai virus, the mouse parainfluenza type 1: A longstanding pathogen that remains up-to-date"},{"title3":"A pneumotropic virus from mice causing hemagglutination"},{"title3":"Enzootic sendai virus infections in mouse breeder colonies within the United States"},{"title3":"A naturally occurring epizootic caused by Sendai virus in breeding and aging rodent colonies. I. Infection in the mouse"},{"title3":"Natural history of sendai virus infection in mice"},{"title3":"Isolation and characterization of novel bat paramyxovirus B16-40 potentially belonging to the proposed genus Shaanvirus"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronaviridae: The viruses and their replication"},{"title3":"Characterization of a coronavirus isolated from a diarrheic foal"},{"title3":"Hospital outbreak of middle east respiratory syndrome coronavirus"},{"title3":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia"},{"title3":"Bats Are Natural Reservoirs of SARS-Like Coronaviruses"},{"title3":"Bats, civets and the emergence of SARS"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis","References":[{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV):update (26 May 2014)"},{"title3":"Clinical management of severe acute respiratory infections when novel coronavirus is suspected: what to do and what not to do"},{"title3":"Treatment of MERS-CoV: decision support tool v.1.0"},{"title3":"State of knowledge and data gaps of middle east respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"Hyperimmune iv immunoglobulin treatment: A multicenter double-blind randomized controlled trial for patients with severe 2009 influenza a(H1N1) infection"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital"},{"title3":"The management of coronavirus infections with particular reference to SARS"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and the effectiveness of convalescent plasma for the treatment of severe acute respiratory infections of viral aetiology: a systematic review. PROSPERO 2013CRD42013005091"},{"title3":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Updated March 2011"},{"title3":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses"},{"title3":"Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective"},{"title3":"Use of serum in the treatment of influenza-pneumonia"},{"title3":"Treatment of influenza with injections of blood from convalescents"},{"title3":"Treatment of influenza pneumonia with serum from convalescents"},{"title3":"Treatment of influenza pneumonia by use of convalescent human serum"},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Clinical research during a public health emergency: a systematic review of severe pandemic influenza management"},{"title3":"Successful treatment of avian influenza with convalescent plasma"},{"title3":"Convalescent plasma for prophylaxis and treatment of severe pandemic influenza A (H1N1) 2009 infection: Case reports"},{"title3":"Treatment of severe acute respiratory syndrome with convalescent plasma"},{"title3":"Treatment with convalescent plasma for influenza A (H5N1) infection"},{"title3":"Clinical characteristics and therapeutic experience of case of severe highly pathogenic A/H5N1 avian influenza with bronchopleural fistula"},{"title3":"Letter to the editor"},{"title3":"Treatment of severe acute respiratory syndrome with convalescent plasma, author reply"},{"title3":"Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1)"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area"},{"title3":"Treatment of influenzal pneumonia with plasma of convalescent patients"},{"title3":"Treatment of influenzal pneumonia by the use of convalescent human serum"},{"title3":"Human serum in influenza"},{"title3":"Clinical characteristics of 26 human cases of highly pathogenic avian 36]influenza A (H5N1) virus infection in China"},{"title3":"Retrospective study on collecting convalescent donors's plasma in treatment of patients with pandemic influenza A (H1N1) virus infection"},{"title3":"Human serum in the treatment of influenza bronchopneumonia"},{"title3":"Convalescent serum in treatment of influenza"},{"title3":"Convalescent serum in the prevention and treatment of influenza"},{"title3":"Plasma therapy in influenza"},{"title3":"Report of influenza treated with serum from recovered cases"},{"title3":"Convalescent serum in the treatment of influenza pneumonia"},{"title3":"The use of the serum of convalescents in the treatment of influenza pneumonia: A summary of the results in a series of one hundred and one cases"},{"title3":"Advances in clinical diagnosis and treatment of severe acute respiratory syndrome"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Serum treatment of postinfluenzal bronchopneumonia"},{"title3":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection"},{"title3":"Treatment of Severe Pandemic Influenza A/H1N1 Infection"},{"title3":"Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product?"}]},{"title2":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis","References":[{"title3":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis"}]},{"title2":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","References":[]},{"title2":"The impact of transmission control measures during the first 50 days of the COVID-19","References":[]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]},{"title2":"World Health Organization, 2019: World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) [EB/OL]. (2019-11-30) [2020-02-18]. https://www.who.int/emergencies/mers-cov/en/.","References":[]},{"title2":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy","References":[]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]}]},{"title1":"Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019","References":[{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","References":[{"title3":"Masters PS, Perlman, S (2013) Coronaviridae. In: Knipe DM, Howley P (eds) Fields Virology. Lippincott Williams and Wilkins, Philadelphia, PA, pp 825-858"},{"title3":"Coronavirus host range expansion and Middle East respiratory syndrome coronavirus emergence: biochemical mechanisms and evolutionary perspectives"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronavirus-associated pneumonia in previously healthy children"},{"title3":"Clinical disease in children associated with newly described coronavirus subtypes"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"van Boheemen S et al (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3(6)"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"WHO Cumulative number of reported probable cases of SARS. In: 2003"},{"title3":"http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140613.pdf WUoM-CTfAtHaIRfA-RGLaoMAf"},{"title3":"WHO: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical and laboratory findings of SARS in Singapore"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"SARS: clinical virology and pathogenesis"},{"title3":"The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"van den Brand JM et al (2014) The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 151(1):83-112"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Chu H et al (2015) Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213(6):904-14"},{"title3":"Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Animal models of Middle East respiratory syndrome coronavirus infection"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Cockrell A et al (2016) A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nature Microbiology 2:16226"},{"title3":"Li K et al (2017) Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proceedings of the National Academy of Sciences 114(15):E3119-E3128"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Interaction of SARS and MERS coronaviruses with the antiviral interferon response"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling"},{"title3":"Interferon and cytokine responses to SARS-coronavirus infection"},{"title3":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Fehr AR et al (2016) The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. mBio 7(6):e01721-16"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain"},{"title3":"Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Initial viral load and the outcomes of SARS"},{"title3":"Proliferative growth of SARS coronavirus in Vero E6 cells"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand"},{"title3":"Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia"},{"title3":"Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Not so fast: adaptive suppression of innate immunity"},{"title3":"Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection"},{"title3":"Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Reghunathan R et al (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunology 6:2"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Zumla A et al (2016) Coronaviruses:drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327-47"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"IFN-lambda resolves inflammation via suppression of neutrophil infiltration and IL-1beta production"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus"},{"title3":"Silencing of CCR2 in myocarditis"},{"title3":"Therapeutic siRNA silencing in inflammatory monocytes in mice"},{"title3":"Immunomodulatory therapy for severe influenza"},{"title3":"The effect of inhibition of PP1 and TNFalpha signaling on pathogenesis of SARS coronavirus"}]},{"title2":"Chen C, Chen C, Yan J, Zhou N, Zhao J, Wang D. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Chinese Journal of Cardiology. doi: 10.3760/cma.j.cn112148-20200225-00123.","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop","References":[]},{"title2":"Cytokine storm and sepsis disease pathogenesis","References":[]},{"title2":"Origin and evolution of pathogenic coronaviruses","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe Acute Respiratory Syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"New insights into the mechanisms of RNA recombination"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure"},{"title3":"RNA recombination in animal and plant viruses"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Bats and coronaviruses"}]},{"title2":"Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al., Severe acute respiratory syndrome-related coronavirus: The species and its viruses-a statement of the Coronavirus Stu***dy Gro***up. bioRxiv 2020. doi: https://doi.org/10.1101/2020.02.07.937862.","References":[]},{"title2":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020"},{"title3":"Liu Y, Gayle AA, Wilder-Smith A, Rocklov J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020. 10.1093/jtm/taaa021."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Giovanetti M, Benvenuto D, Angeletti S, Ciccozzi M. The first two cases of 2019-nCoV in Italy: where they come from? J Med Virol. 2020:1-4. 10.1002/jmv.25699 [Epub ahead of print]."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event"},{"title3":"Bats may be SARS reservoir"},{"title3":"Bats and coronaviruses"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020. 10.1002/jmv.25726 [Epub ahead of print]."},{"title3":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. 10.1056/NEJMoa2002032."},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Clinical and epidemiologic characteristics of spreaders of middle east respiratory syndrome coronavirus during the 2015 outbreak in Korea"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China"},{"title3":"Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID-2019: the role of the nsp2 and nsp3 in its pathogenesis. J Med Virol. 2020. 10.1002/jmv.25719."},{"title3":"Zhang L, Shen FM, Chen F, Lin Z. Origin and evolution of the 2019 novel coronavirus. Clin Infect Dis. 2020. 10.1093/cid/ciaa112 [Epub ahead of print]."},{"title3":"Poultry farms as a source of avian influenza a (H7N9) virus reassortment and human infection"},{"title3":"Tang X, Wu C, Li X, Song Y, Yao X, Wu X, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. 2020. 10.1093/nsr/nwaa036."},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"},{"title3":"Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol. 2020. 10.1128/JVI.00127-20 [Epub ahead of print]."},{"title3":"Structural insights into coronavirus entry"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, et al. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020. 10.1038/s41423-020-0374-2."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Host factors in coronavirus replication"},{"title3":"Coronavirus transcription: a perspective"},{"title3":"Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus"},{"title3":"The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal"},{"title3":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020. 10.1038/s41564-020-0688-y."},{"title3":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"},{"title3":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. 10.1056/NEJMoa2001316 [Epub ahead of print]."},{"title3":"Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect. 2020. 10.1016/j.jmii.2020.02.001 [Epub ahead of print]."},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. 10.1001/jama.2020.1585 [Epub ahead of print]."},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Factors associated with clinical outcome in 25 patients with avian influenza a (H7N9) infection in Guangzhou, China"},{"title3":"Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J. 2020. 10.1097/CM9.0000000000000744 [Epub ahead of print]."},{"title3":"Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020;200230. 10.1148/radiol.2020200230. [Epub ahead of print]."},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"},{"title3":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. 10.1016/s2213-2600(20)30079-5."},{"title3":"Clinical findings in 111 cases of influenza a (H7N9) virus infection"},{"title3":"Wang J, Qi H, Bao L, Li F, Shi Y, National Clinical Research Center for Child H, et al. A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units. Lancet Child Adolesc Health. 2020. 10.1016/S2352-4642(20)30040-7 [Epub ahead of print]."},{"title3":"Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3"},{"title3":"Innate immune sensing and signaling of cytosolic nucleic acids"},{"title3":"Sensing viral invasion by RIG-I like receptors"},{"title3":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA"},{"title3":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3"},{"title3":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling"},{"title3":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors"},{"title3":"Innate immunity to virus infection"},{"title3":"Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies"},{"title3":"General anatomy report of novel coronavirus pneumonia death corpse"},{"title3":"WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed 28 Jan 2020."},{"title3":"Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis. 2020. 10.1016/s1473-3099(20)30141-9."},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Potential antiviral therapeutics for 2019 Novel Coronavirus"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (gs-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"First Case of 2019 Novel Coronavirus in the United States"},{"title3":"Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity"},{"title3":"Effects of chloroquine on viral infections: an old drug against today's diseases?"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Lopinavir/ritonavir: a review of its use in the management of HIV infection"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR"},{"title3":"Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020. 10.5582/bst.2020.01030 [Epub ahead of print]."},{"title3":"Mechanism of inhibition of ebola virus rna-dependent rna polymerase by remdesivir"},{"title3":"Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge"},{"title3":"Strategies of development of antiviral agents directed against influenza virus replication"},{"title3":"A synthetic serine protease inhibitor, Nafamostat Mesilate, is a drug potentially applicable to the treatment of ebola virus disease"},{"title3":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection"},{"title3":"SARS: pharmacotherapy"},{"title3":"Arabi YM, Shalhoub S, Mandourah Y, Al-Hameed F, Al-Omari A, Al Qasim E, et al. Ribavirin and interferon therapy for critically ill patients with middle east respiratory syndrome: a multicenter observational study. Clin Infect Dis. 2019. 10.1093/cid/ciz544 [Epub ahead of print]."},{"title3":"Influenza treatment with oseltamivir outside of labeled recommendations"},{"title3":"Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments"},{"title3":"Antiviral drugs against alphaherpesvirus"},{"title3":"Ganciclovir"},{"title3":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor"},{"title3":"The mechanism of resistance to favipiravir in influenza"},{"title3":"Will there be a cure for Ebola?"},{"title3":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent"},{"title3":"A screen of the NIH clinical collection small molecule library identifies potential anti-coronavirus drugs"},{"title3":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus"},{"title3":"The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus"}]},{"title2":"Constitutive Inflammatory Cytokine Storm: A Major Threat to Human Health","References":[]},{"title2":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","References":[{"title3":"Sepsis definitions: time for change"},{"title3":"The effect of age on the development and outcome of adult sepsis"},{"title3":"Sepsis studies need new direction"},{"title3":"Septic shock--evaluating another failed treatment"},{"title3":"New approaches to the study of sepsis"},{"title3":"The search for effective therapy for sepsis: back to the drawing board?"},{"title3":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach"},{"title3":"The pathophysiology and treatment of sepsis"},{"title3":"Immunotherapy for sepsis--a new approach against an ancient foe"},{"title3":"Immunotherapy - a potential new way forward in the treatment of sepsis"},{"title3":"Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome"},{"title3":"Immunosuppression in patients who die of sepsis and multiple organ failure"},{"title3":"Immunosuppression in sepsis"},{"title3":"Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis"},{"title3":"The late phase of sepsis is characterized by an increased microbiological burden and death rate"},{"title3":"Improved survival with ipilimumab in patients with metastatic melanoma"},{"title3":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer"},{"title3":"Normal responses to injury prevent systemic inflammation and can be immunosuppressive"},{"title3":"A genomic storm in critically injured humans"},{"title3":"The pathogenesis of sepsis"},{"title3":"The ageing haematopoietic stem cell compartment"},{"title3":"Anti-inflammatory cytokine profile and mortality in febrile patients"},{"title3":"Downregulation of proinflammatory cytokine release in whole blood from septic patients"},{"title3":"Dysregulation of in vitro cytokine production by monocytes during sepsis"},{"title3":"Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis"},{"title3":"Genome-wide expression profiling in pediatric septic shock"},{"title3":"Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction"},{"title3":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans"},{"title3":"Depletion of dendritic cells, but not macrophages, in patients with sepsis"},{"title3":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure"},{"title3":"Spleen depletion in neonatal sepsis and chorioamnionitis"},{"title3":"Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock"},{"title3":"Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis"},{"title3":"Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis"},{"title3":"Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity"},{"title3":"Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis"},{"title3":"Over-expression of Bcl-2 provides protection in septic mice by a trans effect"},{"title3":"Immunosuppressive effects of apoptotic cells"},{"title3":"Apoptosis. Gone but not forgotten"},{"title3":"Evolution of neutrophil apoptosis in septic shock survivors and nonsurvivors"},{"title3":"Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome"},{"title3":"Neutrophil paralysis in sepsis"},{"title3":"The function of neutrophils in sepsis"},{"title3":"Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis"},{"title3":"Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients"},{"title3":"Sepsis induces early alterations in innate immunity that impact mortality to secondary infection"},{"title3":"Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study"},{"title3":"Neutrophils are significant producers of IL-10 during sepsis"},{"title3":"A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1"},{"title3":"MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis"},{"title3":"CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress"},{"title3":"A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma"},{"title3":"Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response"},{"title3":"Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology"},{"title3":"Decrease in circulating dendritic cells predicts fatal outcome in septic shock"},{"title3":"Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis"},{"title3":"Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis"},{"title3":"Altered phenotype of blood dendritic cells in patients with acute pneumonia"},{"title3":"Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock"},{"title3":"Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis"},{"title3":"Human monocytes differentiate into dendritic cells subsets that induce anergic and regulatory T cells in sepsis"},{"title3":"Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock"},{"title3":"Dendritic cell modification of neutrophil responses to infection after burn injury"},{"title3":"Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection"},{"title3":"Stimulation of hematopoiesis by the Fms-like tyrosine kinase 3 ligand restores bacterial induction of Th1 cytokines in thermally injured mice"},{"title3":"Septic mice are susceptible to pulmonary aspergillosis"},{"title3":"Reversal of long-term sepsis-induced immunosuppression by dendritic cells"},{"title3":"TLR-4 agonist in post-haemorrhage pneumonia: role of dendritic and natural killer cells"},{"title3":"CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis"},{"title3":"Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis"},{"title3":"Endotoxin tolerance: new mechanisms, molecules and clinical significance"},{"title3":"Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages"},{"title3":"Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock"},{"title3":"IL-10-induced microRNA-187 negatively regulates TNF-alpha, IL-6, and IL-12p40 production in TLR4-stimulated monocytes"},{"title3":"Epigenetic regulation of the alternatively activated macrophage phenotype"},{"title3":"Epigenetic regulation of immune cell functions during post-septic immunosuppression"},{"title3":"mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance"},{"title3":"IFN-gamma abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling"},{"title3":"The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration"},{"title3":"Anti-inflammatory cytokine profile and mortality in febrile patients"},{"title3":"Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options"},{"title3":"Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis"},{"title3":"Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug"},{"title3":"Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock"},{"title3":"Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia"},{"title3":"Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta"},{"title3":"Characterization and modulation of the immunosuppressive phase of sepsis"},{"title3":"Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction"},{"title3":"Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis"},{"title3":"Lymphocyte function in anergic patients"},{"title3":"Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony"},{"title3":"Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies"},{"title3":"Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock"},{"title3":"The role of natural killer cells in sepsis"},{"title3":"Natural killer (NK) cells in antibacterial innate immunity: angels or devils?"},{"title3":"Early assessment of leukocyte alterations at diagnosis of septic shock"},{"title3":"Phenotype and functions of natural killer cells in critically-ill septic patients"},{"title3":"Lymphocyte subset numbers depend on the bacterial origin of sepsis"},{"title3":"Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis"},{"title3":"Toll-like receptors expression and interferon-gamma production by NK cells in human sepsis"},{"title3":"In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2"},{"title3":"Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections"},{"title3":"Suppression of natural killer-cell function in humans following thermal and traumatic injury"},{"title3":"Depressed natural killer cell function in thermally injured adults: successful in vivo and in vitro immunomodulation and the role of endotoxin"},{"title3":"Interferon-gamma production by natural killer cells and cytomegalovirus in critically ill patients"},{"title3":"NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis"},{"title3":"Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation"},{"title3":"Cytomegalovirus reactivation in critically ill immunocompetent patients"},{"title3":"Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges"},{"title3":"The role of viruses in nosocomial pneumonia"},{"title3":"NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection"},{"title3":"Six-of-the-best:unique contributions of gammadelta T cells to immunology"},{"title3":"Association of gammadelta T cells with disease severity and mortality in septic patients"},{"title3":"Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways"},{"title3":"CD4+ T-lymphocyte alterations in trauma patients"},{"title3":"Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome"},{"title3":"Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly"},{"title3":"Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern"},{"title3":"Lymphocyte subset responses to trauma and sepsis"},{"title3":"Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes"},{"title3":"Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression"},{"title3":"Selective defects of T lymphocyte function in patients with lethal intraabdominal infection"},{"title3":"The potential pattern of circulating lymphocytes TH1/TH2 is not altered after multiple injuries"},{"title3":"Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock"},{"title3":"Regulatory T cell populations in sepsis and trauma"},{"title3":"Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis"},{"title3":"Immunity to fungal infections"},{"title3":"Candida albicans morphogenesis and host defence: discriminating invasion from colonization"},{"title3":"Deficient Candida-specific T-helper 17 response during sepsis"},{"title3":"ICU-acquired immunosuppression and the risk for secondary fungal infections"},{"title3":"Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis"},{"title3":"Viral immune evasion due to persistence of activated T cells without effector function"},{"title3":"T cell exhaustion"},{"title3":"Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients"},{"title3":"PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis"},{"title3":"Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis"},{"title3":"PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction"},{"title3":"Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis"},{"title3":"Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling"},{"title3":"Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study"},{"title3":"Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients"},{"title3":"Depletion of natural CD4+CD25+ T regulatory cells with anti-CD25 antibody does not change the course of Pseudomonas aeruginosa-induced acute lung infection in mice"},{"title3":"Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis"},{"title3":"The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth"},{"title3":"Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism"},{"title3":"CD4+ CD25+ Treg cells inhibit human memory gammadelta T cells to produce IFN-gamma in response to M tuberculosis antigen ESAT-6"},{"title3":"CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages"},{"title3":"Harnessing the biology of IL-7 for therapeutic application"},{"title3":"Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation"},{"title3":"IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis"},{"title3":"Decreased T-cell repertoire diversity in sepsis: a preliminary study"},{"title3":"Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study"},{"title3":"IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology"},{"title3":"Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis"},{"title3":"IL-7 restores lymphocyte functions in septic patients"},{"title3":"Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis"},{"title3":"Inhibiting the Programmed Death 1 Pathway Rescues Mycobacterium tuberculosis-Specific Interferon gamma-Producing T Cells From Apoptosis in Patients With Pulmonary Tuberculosis"},{"title3":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment"},{"title3":"Immune effects of interferon gamma in persistent staphylococcal sepsis"},{"title3":"Long-term interferon-gamma therapy for patients with chronic granulomatous disease"},{"title3":"Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial"},{"title3":"Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis"},{"title3":"A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group"},{"title3":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial"},{"title3":"New approaches to sepsis: molecular diagnostics and biomarkers"},{"title3":"Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?"},{"title3":"Genetics and genomics in pediatric septic shock"},{"title3":"Of mice and not men: differences between mouse and human immunology"},{"title3":"Genomic responses in mouse models poorly mimic human inflammatory diseases"},{"title3":"Targeted delivery of siRNA to cell death proteins in sepsis"},{"title3":"Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis"}]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","References":[{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Severe Acute Respiratory Syndrome (SARS) Epidemiology Working Group. WHO consensus document on the epidemiology of severe acute respiratory syndrome (SARS). (http://www.who.int/csr/sars/en/WHOconsensus.pdf, 2003)."},{"title3":"Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology"},{"title3":"Updating the accounts: global mortality of the 1918-1920 &quot;Spanish&quot; influenza pandemic"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"World Health Organization. Confirmed human cases of avian influenza A (H5N1), 7 September 2004. (http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2004_09_07/en/print.html, 2004)."},{"title3":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Imai, Y. et al. The SARS-coronavirus receptor angiotensin coverting enzyme 2 protects from severe acute lung failure. Nature (in the press)."},{"title3":"Chemokine receptor trafficking and viral replication"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Human coronaviruses-a brief review"},{"title3":"ACE1 polymorphism and progression of SARS"},{"title3":"Analysis on the SARS-CoV genome of PUMC01 isolate"},{"title3":"Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation"}]},{"title2":"Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al., Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. medRxiv 2020. doi: https://doi.org/10.1101/2020.02.16.20023671.","References":[]},{"title2":"Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al., Neutrophil-to-Lymphocyte Ratio Predicts Severe illness Patients with 2019 Novel Coronavirus in the Early Stage. medRxiv 2020. doi: https://doi.org/10.1101/2020.02.10.20021584.","References":[]},{"title2":"The cytokine storm of severe influenza and development of immunomodulatory therapy","References":[{"title3":"1918 Influenza: the mother of all pandemics"},{"title3":"Characteristics of human infection with avian influenza viruses and development of new antiviral agents"},{"title3":"Clinical characteristics of human infection with a novel avian-origin influenza A(H10N8) virus"},{"title3":"Host response to influenza virus: protection versus immunopathology"},{"title3":"Into the eye of the cytokine storm"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"A question of self-preservation: immunopathology in influenza virus infection"},{"title3":"Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque"},{"title3":"Structured regulation of inflammation during respiratory viral infection"},{"title3":"Innate immune responses to influenza A H5N1: friend or foe?"},{"title3":"Recognition of microorganisms and activation of the immune response"},{"title3":"A calculated response: control of inflammation by the innate immune system"},{"title3":"Genetic insights into sepsis: what have we learned and how will it help?"},{"title3":"Avian influenza A (H5N1) infection in humans"},{"title3":"Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy"},{"title3":"Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses"},{"title3":"Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus"},{"title3":"Characterizing and controlling the inflammatory network during influenza A virus infection"},{"title3":"Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury"},{"title3":"Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"title3":"Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection"},{"title3":"Immunomodulatory therapy for severe influenza"},{"title3":"Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice"},{"title3":"Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan"},{"title3":"Increased survival after gemfibrozil treatment of severe mouse influenza"},{"title3":"Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus"},{"title3":"Bezafibrate upregulates carnitine palmitoyltransferase II expression and promotes mitochondrial energy crisis dissipation in fibroblasts of patients with influenza-associated encephalopathy"},{"title3":"PPAR-gamma activation as an anti-inflammatory therapy for respiratory virus infections"},{"title3":"Using complementary and alternative medicines to target the host response during severe influenza"},{"title3":"Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection"},{"title3":"Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice"},{"title3":"Drugs to cure avian influenza infection - multiple ways to prevent cell death"},{"title3":"N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus"},{"title3":"Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression"},{"title3":"Ascorbic acid role in containment of the world avian flu pandemic"},{"title3":"Inhibition of influenza A virus replication by resveratrol"},{"title3":"Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A"},{"title3":"Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells"},{"title3":"N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection"},{"title3":"Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia"},{"title3":"Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection"},{"title3":"Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice"},{"title3":"Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases"},{"title3":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection"},{"title3":"Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis"},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Treating influenza with statins and other immunomodulatory agents"},{"title3":"Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice"},{"title3":"Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia"},{"title3":"Potential mechanisms of AT1 receptor blockers on reducing pneumonia-related mortality"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes"},{"title3":"CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection"},{"title3":"Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice"},{"title3":"A critical role for OX40 in T cell-mediated immunopathology during lung viral infection"},{"title3":"Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection"},{"title3":"Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases"},{"title3":"Arbidol as a broad-spectrum antiviral: an update"},{"title3":"Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection"},{"title3":"65Guidelines for Management of Avian H7N9 Influenza Infection. Available from: http://www.moh.gov.cn/ewebeditor/uploadfile/2013/04/20130410212136993.doc."},{"title3":"66Guidelines for Management of Pandemic (H1N1) 2009 Influenza. Available from: http://www.moh.gov.cn/mohwsyjbgs/s9990/200910/43111.shtml."},{"title3":"Chinese medicinal herbs for influenza: a systematic review"},{"title3":"Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials"},{"title3":"Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: a self-control study"},{"title3":"Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory viral infections in vitro and in vivo"},{"title3":"Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea"}]},{"title2":"Liu T, Zhang J, Yang Y, Ma H, Li Z, Zhang J, et al., The potential role of IL-6 in monitoring severe case of coronavirus disease 2019. medRxiv 2020. doi: https://doi.org/10.1101/2020.03.01.20029769.","References":[]},{"title2":"The immunology of hypertension","References":[]},{"title2":"Peng Y, Meng K, Guan H, Leng L, Zhu R, Wang B, et al., Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Chinese Journal of Cardiology 2020. doi: 10.3760/cma.j.cn112148-20200220-00105.","References":[]},{"title2":"The Vasoactive Mas Receptor in Essential Hypertension","References":[{"title3":"Worldwide prevalence of hypertension exceeds 1.3 billion"},{"title3":"Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries"},{"title3":"2018 ESC/ESH guidelines for the management of arterial hypertension"},{"title3":"2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines"},{"title3":"The hypertension pandemic: An evolutionary perspective"},{"title3":"Genetic and molecular aspects of hypertension"},{"title3":"Essential hypertension: Part II: Treatment"},{"title3":"Epigenetic modifications in essential hypertension"},{"title3":"High-salt diet and hypertension: Focus on the renin-angiotensin system"},{"title3":"Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension"},{"title3":"Angiotensin II signal transduction: An update on mechanisms of physiology and pathophysiology"},{"title3":"New approaches in the treatment of hypertension"},{"title3":"The renin-angiotensin-aldosterone system and its therapeutic targets"},{"title3":"Hypertension: Renin-angiotensin-aldosterone system alterations"},{"title3":"Key developments in renin-angiotensin-aldosterone system inhibition"},{"title3":"Angiotensin II type 2 receptor agonists: Where should they be applied?"},{"title3":"An update on the tissue renin angiotensin system and its role in physiology and pathology"},{"title3":"Angiotensin-(1-12): A chymase-mediated cellular Angiotensin II substrate"},{"title3":"Angiotensin III: A physiological relevant peptide of the renin angiotensin system"},{"title3":"Emerging therapy in hypertension"},{"title3":"What's new in the renin-angiotensin system?"},{"title3":"Ganging up on Angiotensin II type 1 receptors in vascular remodeling"},{"title3":"Recent insights and therapeutic perspectives of Angiotensin-(1-9) in the cardiovascular system"},{"title3":"Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/ang ii axis"},{"title3":"Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases"},{"title3":"The meaning of MAS"},{"title3":"Characterization of a new angiotensin antagonist selective for Angiotensin-(1-7): Evidence that the actions of Angiotensin-(1-7) are mediated by specific angiotensin receptors"},{"title3":"Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor"},{"title3":"Cardioprotective Angiotensin-(1-7) peptide acts as a natural-biased ligand at the angiotensin II type 1 receptor"},{"title3":"Angiotensin A/Alamandine/MrgD axis: Another clue to understanding cardiovascular pathophysiology"},{"title3":"Angiotensin (1-7) and alamandine: Similarities and differences"},{"title3":"Clinical practice guidelines for the management of hypertension in the community: A statement by the american society of hypertension and the international society of hypertension"},{"title3":"Release of vasopressin from the rat hypothalamo-neurohypophysial system by Angiotensin-(1-7) heptapeptide"},{"title3":"Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies"},{"title3":"Angiotensin-(1-7) counterregulates Angiotensin II signaling in human endothelial cells"},{"title3":"ACE2: More of Ang-(1-7) or less Ang II?"},{"title3":"Angiotensin type 2 receptor (AT2R) and receptor mas: A complex liaison"},{"title3":"G-protein-coupled receptor MAS is a physiological antagonist of the Angiotensin II type 1 receptor"},{"title3":"The ACE2/Angiotensin-(1-7)/MAS axis of the renin-angiotensin system: Focus on angiotensin-(1-7)"},{"title3":"Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains"},{"title3":"Production of Angiotensin-(1-7) by human vascular endothelium"},{"title3":"Inhibition of mas g-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection"},{"title3":"AVE 0991, a nonpeptide mimic of the effects of Angiotensin-(1-7) on the endothelium"},{"title3":"Addition of cyclic Angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy"},{"title3":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents"},{"title3":"The endothelium-dependent vasodilator effect of the nonpeptide Ang (1-7) mimic AVE 0991 is abolished in the aorta of Mas-knockout mice"},{"title3":"Short-term Angiotensin (1-7) receptor mas stimulation improves endothelial function in normotensive rats"},{"title3":"Evidence for Mas-mediated bradykinin potentiation by the Angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats"},{"title3":"Angiotensin-(1-7): New perspectives in atherosclerosis treatment"},{"title3":"An oral formulation of Angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats"},{"title3":"The effect of the thioether-bridged, stabilized Angiotensin-(1-7) analogue cyclic Ang-(1-7) on cardiac remodeling and endothelial function in rats with myocardial infarction"},{"title3":"Angiotensin-(1-7)"},{"title3":"Angiotensin-converting enzyme 2 and Angiotensin 1-7: Novel therapeutic targets"},{"title3":"Evidence for heterodimerization and functional interaction of the Angiotensin type 2 receptor and the receptor mas"},{"title3":"Heteromerization between the bradykinin b2 receptor and the Angiotensin-(1-7) mas receptor: Functional consequences"},{"title3":"Beneficial effects of long-term administration of an oral formulation of Angiotensin-(1-7) in infarcted rats"},{"title3":"Brain renin-angiotensin system blockade by systemically active aminopeptidase a inhibitors: A potential treatment of salt-dependent hypertension"},{"title3":"Evolution of a new class of antihypertensive drugs: Targeting the brain renin-angiotensin system"},{"title3":"Alamandine acts via MrgD to induce AMPK/NO activation against Ang II hypertrophy in cardiomyocytes"},{"title3":"Alamandine protects the heart against reperfusion injury via the MrgD receptor"},{"title3":"Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats"}]},{"title2":"Shi Y, Ou J, Chen X, Tan M, Li F, Liu Y. Expressions of multiple inflammation markers in the patients with 2019 novel coronavirus pneumonia and their clinical values. Chinese Journal of Laboratory Medicine 2020. doi: 10.3760/cma.j.cn114452-20200214-00073.","References":[]},{"title2":"Immunotherapeutic implications of IL-6 blockade for cytokine storm","References":[]},{"title2":"Wang C, Xie J, Zhao L, Fe X, Zhang H, Tan Y, et al., Aveolar Macrophage Activation and Cytokine Storm in the Pathogenesis of Severe COVID-19. 25 March 2020, PREPRINT (Version 1) available at Research Square [+https://doi.org/10.21203/rs.3.rs-19346/v1+].","References":[]},{"title2":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al., Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020. doi: 10.1001/jama.2020.1585.","References":[]},{"title2":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","References":[{"title3":"A multicentre collaboration to investigate the cause of severe acute respiratory syndrome."},{"title3":". Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS) [monograph on the Internet]. [cited July 11, 2003]. Available from: http://www.who.int/csr/sars/country/en"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong."},{"title3":"Clinical progression and viral load in a community-outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome."},{"title3":". Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34 [monograph on the Internet]. [cited May 5, 2003]. Available from: http://www.who.int/csr/don/2003_04_19/en/"},{"title3":". International SARS case report form [monograph on the Internet]. [cited Mar 27, 2003]. Available from: http://www.cdc.gov/ncidod/sars/pdf/intcasereportform-sars.pdf"},{"title3":"Gram-negative bacteremia."},{"title3":"Severe acute respiratory syndrome:Taiwan, 2003."},{"title3":"Induction of postinflammatory cytokines in human macrophages by influenza A (H5N1) virus: a mechanism for the unusual severity of human disease?"},{"title3":"The joint associations of multiple risk factors with the occurrence of nosocomial infection."},{"title3":"Patient data, early SARS epidemic, Taiwan."},{"title3":"Intravenously administered immune globulin for the treatment of infection-associated hemophagocytotic syndrome."},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area."},{"title3":"Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus."},{"title3":"Applications of acute phase reactants in infectious diseases."},{"title3":"C-reactive protein in the prediction of cardiovascular events."},{"title3":"Infectious etiologies of rhabdomyolysis: three case reports and review."},{"title3":"The spectrum of rhabdomyolysis."},{"title3":"Rhabdomyolysis associated with probable SARS."},{"title3":"Infectious myelopathies."},{"title3":"Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure."}]},{"title2":"Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol 2020. doi: 10.1002/jmv.25748.","References":[]},{"title2":"Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa272.","References":[]},{"title2":"Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis 2020. doi: 10.1016/j.ijid.2020.03.004.","References":[]},{"title2":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2","References":[{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Quality Appraisal of Case Series Studies Checklist"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Computed tomography features of patients with novel coronavirus pneumonia"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury (Chinese)"},{"title3":"CT features of patients with imported 2019-nCoV-pneumonia"},{"title3":"Preliminary explore on CT characteristics of coronavirus disease 2019 (COVID-19)"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China"},{"title3":"The epidemiological and clinical characteristics of 2019 novel coronavirus infection in Changsha, China"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"},{"title3":"Analysis of CT features of 15 children with 2019 novel coronavirus infection"},{"title3":"Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Chest CT performance and clinical characteristics of coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical and epidemiological characteristics of 26 patients dia gnosed with novel coronavirus pneumonia"},{"title3":"Wang K, Kang SR, Tian RH, et al. CT characteristic appearances of patients with novel coronavirus pneumonia. J Clin Med. 2020;1(27):27-31."},{"title3":"Retrospective analysis of COVID-19 patients with different clinical subtypes"},{"title3":"CT findings in 2019 novel coronavirus disease (COVID-19) patients"},{"title3":"Application of chest CT examination in screening of patients with novel coronavirus pneumonia"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"CT manifestations and dynamic changes of coronavirus disease 2019"},{"title3":"Clinical diagnosis and treatment of critical patients with novel coronavirus pneumonia (report of 12 cases)"},{"title3":"Analysis of clinical and imaging features of novel coronavirus pneumonia in Chongqing traditional Chinese medicine system"},{"title3":"Clinical characteristics and CT signs of coronavirus disease 2019 (COVID-19) in the elderly"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Chest CT features of COVID-19"},{"title3":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia"},{"title3":"An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)"},{"title3":"Systematic solution of new coronavirus pneumonia in dead cadavers"},{"title3":"Study on the mechanism of liver enzyme abnormality in pneumonia infected by novel coronavirus"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Risk assessment of novel coronavirus COVID-19 outbreaks outside China"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"The neglected dimension of global security:a framework for countering infectious-disease crises"}]},{"title2":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al., Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv 2020. doi:https://doi.org/10.1101/2020.01.22.914952.","References":[]},{"title2":"Zhou Y, Fu B, Zheng X, Wang D, Zhao C, qi Y, et al., Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus. bioRxiv 2020. doi: https://doi.org/10.1101/2020.02.12.945576.","References":[]}]},{"title1":"Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19","References":[{"title2":"Novel coronavirus : China","References":[]},{"title2":"Coronavirus disease (COVID-19) outbreak situation","References":[{"title3":"Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures"},{"title3":"SARS-CoV-2 is an appropriate name for the new coronavirus"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"A review of coronavirus Disease-2019 (COVID-19)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status"},{"title3":"Bibliometrics basics"},{"title3":"Scientific publication, bibliometric indicators, and Hirsch's h-index"},{"title3":"Bibliometric methods: pitfalls and possibilities"},{"title3":"Global research trends of Middle East respiratory syndrome coronavirus: a bibliometric analysis"},{"title3":"Global research trends in West Nile virus from 1943 to 2016: a bibliometric analysis"},{"title3":"Analysing published global Ebola virus disease research using social network analysis"},{"title3":"Bibliometric analysis of literature in AIDS-related stigma and discrimination"},{"title3":"Bibliometric analysis of oncolytic virus research, 2000 to 2018"},{"title3":"Bibliometric analysis of Oropouche research: impact on the surveillance of emerging arboviruses in Latin America"},{"title3":"Bibliometric assessment of scientific production of literature of West Nile virus"},{"title3":"Bibliometric indicators of the Zika outbreak"},{"title3":"Bibliometric study of international scientific production in O'nyong-nyong virus during the years 1962-2016"},{"title3":"Bibliometrics of global Ebola virus disease research as seen through science citation index expanded during 1987-2015"},{"title3":"Global research output on HIV/AIDS-related medication adherence from 1980 to 2017"},{"title3":"Del Carpio OL. Guillain-Barre syndrome associated with zika virus infection in the Americas: a bibliometric study. Neurologia. 2020;35(6):426-9."},{"title3":"Scientometric analysis of research on Zika virus"},{"title3":"When has it been studied about La Crosse virus?: Bibliometric analysis of world scientific production"},{"title3":"Andersen JP, Nielsen MW, Simone NL, Lewiss RE, Jagsi R. COVID-19 medical papers have fewer women first authors than expected. Elife. 2020;9:e58807."},{"title3":"A Bibliometric analysis of COVID-19 research activity: a call for increased output"},{"title3":"The scientific literature on coronaviruses, COVID-19 and its associated safety-related research dimensions: a scientometric analysis and scoping review"},{"title3":"Unprecedented surge in publications related to COVID-19 in the first three months of pandemic: a bibliometric analytic report"},{"title3":"Coronavirus disease 2019: a bibliometric analysis and review"},{"title3":"The status and trends of coronavirus research: a global bibliometric and visualized analysis"},{"title3":"COVID-19 will stimulate a new coronavirus research breakthrough: a 20-year bibliometric analysis"},{"title3":"Zhai F, Zhai Y, Cong C, Song T, Xiang R, Feng T, Liang Z, Zeng Y, Yang J, Yang J, et al. Research Progress of Coronavirus Based on Bibliometric Analysis. Int J Environ Res Public Health. 2020;17(11):3766."},{"title3":"Zhou Y, Chen L. Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis. Int J Environ Res Public Health. 2020;17(9):3082."},{"title3":"Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses"},{"title3":"Comparisons of citations in web of science, Scopus, and Google scholar for articles published in general medical journals"},{"title3":"The journal coverage of web of science and Scopus: a comparative analysis"},{"title3":"Global research trends in microbiome-gut-brain axis during 2009-2018: a bibliometric and visualized study"},{"title3":"Global scientific trends on aflatoxin research during 1998-2017: a bibliometric and visualized study"},{"title3":"Arab world's growing contribution to global leishmaniasis research (1998-2017): a bibliometric study"},{"title3":"Polimeni a: coronavirus disease (COVID-19): a machine learning Bibliometric analysis"},{"title3":"Software survey: VOSviewer, a computer program for bibliometric mapping"},{"title3":"Citation-based clustering of publications using CitNetExplorer and VOSviewer"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-42."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"HLH across Speciality collaboration UK: COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Ten-years trend of dengue research in Indonesia and south-east Asian countries: a bibliometric analysis"},{"title3":"Bibliometric analysis of global Lassa fever research (1970-2017): a 47 - year study"},{"title3":"Global research trends of World Health Organization's top eight emerging pathogens"},{"title3":"Dengue research: a bibliometric analysis of worldwide and Arab publications during 1872-2015"},{"title3":"Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C et al: First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020;25(6):2000094."},{"title3":"Marchand-Senecal X, Kozak R, Mubareka S, Salt N, Gubbay JB, Eshaghi A, Allen V, Li Y, Bastien N, Gilmour M, et al. Diagnosis and Management of First Case of COVID-19 in Canada: lessons applied from SARS. Clin Infect Dis. 2020. 10.1093/cid/ciaa227."},{"title3":"Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak"},{"title3":"Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020;323(14):1335."},{"title3":"Spiteri G, Fielding J, Diercke M, Campese C, Enouf V, Gaymard A, Bella A, Sognamiglio P, Sierra Moros MJ, Riutort AN, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European region, 24 January to 21 February 2020. Euro Surveill. 2020;25(9):2000178."},{"title3":"A Bibliometric analysis of publications on spinal cord injury during 1980-2018"},{"title3":"Three options for citation tracking: Google scholar, Scopus and Web of Science"},{"title3":"A bibliometric analysis of the global research on biosimilars"},{"title3":"Global scientific production on illicit drug addiction: a two-decade analysis"},{"title3":"Taking the next step in publication productivity analysis in pediatric neurosurgery"},{"title3":"Global output of research on epidermal parasitic skin diseases from 1967 to 2017"},{"title3":"Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis"},{"title3":"Bibliometric analysis of research on the role of intestinal microbiota in obesity"},{"title3":"Investigating global trends in paraquat intoxication research from 1962 to 2015 using bibliometric analysis"},{"title3":"Bibliometrics: tracking research impact by selecting the appropriate metrics"}]},{"title2":"Covid-19 in critically ill patients in the seattle region - case series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[]},{"title2":"Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility","References":[]},{"title2":"Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease","References":[{"title3":"Interstitial lung diseases that are difficult to classify: a review of bronchiolocentric interstitial lung disease"},{"title3":"Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis"},{"title3":"Interstitial lung disease in connective tissue disorders"},{"title3":"Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease"},{"title3":"Lung-specific loss of alpha3 laminin worsens bleomycin-induced pulmonary fibrosis"},{"title3":"Differential expression of collagens type I and type IV in lymphangiogenesis during the angiogenic process associated with bleomycin-induced pulmonary fibrosis in rat"},{"title3":"Post-translational processing of procollagens"},{"title3":"Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis"},{"title3":"Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology"},{"title3":"Clinical significance of serum hyaluronan in chronic fibrotic interstitial pneumonia"},{"title3":"Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study"},{"title3":"Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis"},{"title3":"Hyaluronic acid as a non-invasive biomarker of liver fibrosis"},{"title3":"An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias"},{"title3":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis"},{"title3":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative"},{"title3":"Polymyositis and dermatomyositis (first of two parts)"},{"title3":"The 1982 revised criteria for the classification of systemic lupus erythematosus"},{"title3":"Classification criteria of Sjogren's syndrome"},{"title3":"Mixed connective tissue disease:an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)"},{"title3":"High resolution computed tomography in early scleroderma lung disease"},{"title3":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis"},{"title3":"Active remodeling in idiopathic interstitial pneumonias: evaluation of collagen types XII and XIV"},{"title3":"Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis"},{"title3":"Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid from patients with pulmonary fibrosis"},{"title3":"Procollagen type III amino terminal propeptide concentrations in dogs with idiopathic pulmonary fibrosis compared with chronic bronchitis and eosinophilic bronchopneumopathy"},{"title3":"Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT"},{"title3":"Relevance analysis of clinical and lung function parameters changing and prognosis of idiopathic pulmonary fibrosis"},{"title3":"Anticoagulant therapy for idiopathic pulmonary fibrosis"},{"title3":"Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features"},{"title3":"Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome"},{"title3":"Clinical characteristics of connective tissue disease-associated interstitial lung disease in 1,044 Chinese patients"}]},{"title2":"Clinical significance of serum hyaluronan in chronic fibrotic interstitial pneumonia","References":[]},{"title2":"[Interpretation of pathological changes for &quot;Guidelines for the Diagnosis and treatment of COVID-19 by the national Health commission (trial version 7)&quot;]","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]}]},{"title1":"Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19","References":[{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Cardiac troponin I is an independent predictor for mortality in hospitalized patients with COVID-19.","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China."},{"title3":"Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China [published online March 25, 2020]."}]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.","References":[]},{"title2":"Unexpected features of cardiac pathology in COVID-19 infection.","References":[]},{"title2":"High-sensitivity cardiac troponin can be an ally in the fight against COVID-19.","References":[]},{"title2":"Endothelial cell infection and endotheliitis in COVID-19.","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Offline: COVID-19:bewilderment and candour"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2"},{"title3":"The assessment of endothelial function: from research into clinical practice"},{"title3":"Endothelial dysfunction - a marker of atherosclerotic risk"},{"title3":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion"},{"title3":"Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients"},{"title3":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis"},{"title3":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"}]},{"title2":"The multiple facets of the TGF-beta family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1.","References":[]},{"title2":"Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals.","References":[]},{"title2":"Growth differentiation factor 15 as a biomarker in cardiovascular disease.","References":[{"title3":"Diabetic kidney disease: a report from an ADA Consensus Conference"},{"title3":"Use of proteomics to investigate kidney function decline over 5 years"},{"title3":"Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria"},{"title3":"Biomarkers of diabetic kidney disease"},{"title3":"Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease"},{"title3":"A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study"},{"title3":"A study of middle-aged men with particular reference to risk factors for cardiovascular disease"},{"title3":"Physical activity, obesity and risk of cardiovascular disease in middle-aged men during a median of 30 years of follow-up"},{"title3":"Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes"},{"title3":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability"},{"title3":"Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease"},{"title3":"Multiple imputation by chained equations: what is it and how does it work?"},{"title3":"Frailty models for survival data"},{"title3":"Temporal trends in the prevalence of diabetic kidney disease in the United States"},{"title3":"Markers of and risk factors for the development and progression of diabetic kidney disease"},{"title3":"Applying proteomics to diagnosis of diabetic kidney disease"},{"title3":"Lambers Heerspink HJ. Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression"},{"title3":"Biomarkers of rapid chronic kidney disease progression in type 2 diabetes"},{"title3":"A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes"},{"title3":"GDF-15 as a Target and biomarker for diabetes and cardiovascular diseases: a translational prospective"},{"title3":"Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact"},{"title3":"Growth differentiation factor 15 as a novel biomarker for metformin"},{"title3":"GDF15 is a novel biomarker for impaired fasting glucose"},{"title3":"Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity"},{"title3":"Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD)"},{"title3":"Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmo Diet and Cancer-Cardiovascular Cohort"},{"title3":"Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes"},{"title3":"Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy"},{"title3":"Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis"},{"title3":"Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study"},{"title3":"Predictive properties of biomarkers GDF-15, NTproBNP, and hs-TnT for morbidity and mortality in patients with type 2 diabetes with nephropathy"},{"title3":"Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - an observational follow-up study"},{"title3":"Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes"},{"title3":"Association between growth differentiation factor 15 (GDF15) and cardiovascular risk in patients with newly diagnosed type 2 diabetes mellitus"},{"title3":"Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men"},{"title3":"Urinary kidney injury molecule 1 and incidence of heart failure in elderly men"},{"title3":"Clinical outcome of renal tubular damage in chronic heart failure"},{"title3":"Polymorphisms of the TIM-1 gene are associated with rheumatoid arthritis in the Chinese Hui minority ethnic population"},{"title3":"Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis"},{"title3":"Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease"},{"title3":"Myoglobinuria"},{"title3":"Prognostic implications of plasma myoglobin levels in patients with chronic kidney disease"},{"title3":"Matrix metalloproteinases and subclinical atherosclerosis in chronic kidney disease: a systematic review"},{"title3":"Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease"},{"title3":"Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients"},{"title3":"P. Role of mesangial expansion in the pathogenesis of diabetic nephropathy"}]},{"title2":"Growth differentiation factor-15 is a predictor of mortality in critically ill patients with sepsis.","References":[{"title3":"The third international consensus definitions for sepsis and septic shock (sepsis-3)"},{"title3":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care"},{"title3":"Sepsis: definition, epidemiology, and diagnosis"},{"title3":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock"},{"title3":"Implementation of the surviving sepsis campaign guidelines for severe sepsis and septic shock: we could go faster"},{"title3":"Sepsis biomarkers: a review"},{"title3":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury"},{"title3":"Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues"},{"title3":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily"},{"title3":"Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay"},{"title3":"Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction"},{"title3":"Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction"},{"title3":"Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome"},{"title3":"Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism"},{"title3":"Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease"},{"title3":"Biomarkers of cardiovascular stress and incident chronic kidney disease"},{"title3":"Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study"},{"title3":"Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury"},{"title3":"Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms"},{"title3":"Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction"},{"title3":"Concise review: growth differentiation factor 15 in pathology: a clinical role?"},{"title3":"Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases"},{"title3":"Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients"},{"title3":"Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients"},{"title3":"Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients"},{"title3":"Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients"},{"title3":"Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis"},{"title3":"Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients"},{"title3":"Statistical evaluation of a biomarker"},{"title3":"Growth-differentiation factor-15 in heart failure"},{"title3":"Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality"},{"title3":"GDF 15-a novel biomarker in the offing for heart failure"},{"title3":"Dynamic lactate indices as predictors of outcome in critically ill patients"},{"title3":"Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression"},{"title3":"GDF-15 contributes to proliferation and immune escape of malignant gliomas"},{"title3":"Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury"},{"title3":"Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside"}]},{"title2":"GDF-15 is associated with cancer incidence in patients with type 2 diabetes.","References":[]},{"title2":"Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmo diet and cancer-cardiovascular cohort.","References":[{"title3":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily"},{"title3":"The multiple facets of the TGF-beta family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1"},{"title3":"Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes"},{"title3":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1"},{"title3":"Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal &amp; obesogenic diets"},{"title3":"hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling"},{"title3":"NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism"},{"title3":"Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus"},{"title3":"Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study"},{"title3":"Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet"},{"title3":"The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients"},{"title3":"Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus"},{"title3":"Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial"},{"title3":"Novel biomarkers for predicting cardiovascular disease in patients with diabetes"},{"title3":"Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study"},{"title3":"The Malmo Diet and Cancer Study. Design and feasibility"},{"title3":"Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden"},{"title3":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation"},{"title3":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge"},{"title3":"CVD I 96x96 - Olink. Available at https://www.olink.com/content/uploads/2015/12/0696-v1.3-Proseek-Multiplex-CVD-I-Validation-Data_final.pdf. Last accessed 23 July 2018"},{"title3":"Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood"},{"title3":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability"},{"title3":"GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men"},{"title3":"Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus"},{"title3":"Sugar-sweetened beverage consumption and genetic predisposition to obesity in 2 Swedish cohorts"},{"title3":"Body-mass index and risk of 22 specific cancers:a population-based cohort study of 5.24 million UK adults"},{"title3":"Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions"},{"title3":"PSHREG:a SAS macro for proportional and nonproportional subdistribution hazards regression"},{"title3":"Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study"},{"title3":"Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002"},{"title3":"Maintaining system homeostasis: the third law of Newtonian immunology"},{"title3":"The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation"},{"title3":"A crucial role for adipose tissue p53 in the regulation of insulin resistance"},{"title3":"p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms"},{"title3":"Diabetes mellitus related biomarker: the predictive role of growth-differentiation factor-15"},{"title3":"Doerstling S, Hedberg P, Ohrvik J, Leppert J, Henriksen E (2018) Growth differentiation factor 15 in a community-based sample:age-dependent reference limits and prognostic impact. Ups J Med Sci 123(2):86-93"},{"title3":"Macrophage inhibitory cytokine-1/growth differentiation factor 15 as a marker of cognitive ageing and dementia"},{"title3":"Fujita Y, Taniguchi Y, Shinkai S, Tanaka M, Ito M (2016) Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders. Geriatr Gerontol Int 16 (Suppl 1):17-29. 10.1111/ggi.12724"},{"title3":"Growth Differentiation Factor 15 is a novel diagnostic biomarker of mitochondrial diseases"},{"title3":"Potential biomarkers of ageing"},{"title3":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases:a translational prospective"},{"title3":"Novel and conventional biomarkers for prediction of incident cardiovascular events in the community"},{"title3":"Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals"},{"title3":"Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults:the rancho Bernardo study"},{"title3":"Screening for type 2 diabetes"},{"title3":"Telomere length, stem cells and aging"}]},{"title2":"Daily report and statistics about coronavirus and COVID-19.","References":[]},{"title2":"National Early Warning Score (NEWS) 2: Standardising the assessment of acute-illness severity in the NHS.","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"Growth differentiation factor-15 deficiency augments inflammatory response and exacerbates septic heart and renal injury induced by lipopolysaccharide.","References":[{"title3":"Bhan, C., Dipankar, P., Chakraborty, P. &amp; Sarangi, P.P. Role of cellular events in the pathophysiology of sepsis. Inflammation research: official journal of the European Histamine Research Society ... [et al.] (2016)."},{"title3":"Husak, L. et al. National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada. Healthcare quarterly (Toronto, Ont.) 13 Spec No, 35-41 (2010)."},{"title3":"JAMA patient page. Sepsis"},{"title3":"Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies"},{"title3":"Sepsis and acute kidney injury"},{"title3":"The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules"},{"title3":"Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group"},{"title3":"Unsicker, K., Spittau, B. &amp; Krieglstein, K. The multiple facets of the TGF-beta family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1. Cytokine Growth Factor Rev (2013)."},{"title3":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily"},{"title3":"Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta"},{"title3":"Concise review: growth differentiation factor 15 in pathology: a clinical role?"},{"title3":"Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury"},{"title3":"NAG-1/GDF15 transgenic mouse has less white adipose tissue and a reduced inflammatory response"},{"title3":"Animal models of sepsis: setting the stage"},{"title3":"ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation"},{"title3":"Nitric oxide generation mediates lipid A-induced oxidant injury in renal proximal tubules"},{"title3":"Plasma MIC-1 and PAPP-a levels are decreased among women presenting to an early pregnancy assessment unit, have fetal viability confirmed but later miscarry"},{"title3":"The TGF-beta superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism"},{"title3":"Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction"},{"title3":"Growth differentiation factor-15 and cardiovascular dysfunction and disease: malefactor or innocent bystander?"},{"title3":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury"},{"title3":"Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study"},{"title3":"Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure"},{"title3":"GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice"},{"title3":"Growth differentiation factor 15 in heart failure: an update"},{"title3":"GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective"},{"title3":"GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma"},{"title3":"Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia"},{"title3":"Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney"},{"title3":"MCP-1 gene activation marks acute kidney injury"},{"title3":"Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent"},{"title3":"Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate"},{"title3":"Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes"},{"title3":"Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury"},{"title3":"Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin"}]},{"title2":"Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury.","References":[]},{"title2":"Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.","References":[{"title3":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily"},{"title3":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury"},{"title3":"Antiangiogenic activity of the MDM2 antagonist nutlin-3"},{"title3":"Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery"},{"title3":"Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes"},{"title3":"GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation"},{"title3":"Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction"},{"title3":"Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure"},{"title3":"Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction"},{"title3":"Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome"},{"title3":"Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected non-necrosis biomarkers"},{"title3":"Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan heart failure trial"},{"title3":"Benchmarks for the assessment of novel cardiovascular biomarkers"},{"title3":"The report card on growth differentiation factor 15: consistent marks but not yet ready for promotion"},{"title3":"The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health"},{"title3":"African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study"},{"title3":"Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study"},{"title3":"Heart disease and stroke statistics-2010 update: a report from the American Heart Association"},{"title3":"Race and gender differences in C-reactive protein levels"},{"title3":"Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study)"},{"title3":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population"},{"title3":"Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay"},{"title3":"Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis)"},{"title3":"Several methods to assess improvement in risk prediction models: extension to survival analysis"},{"title3":"Estimation of time-dependent area under the ROC curve for long-term risk prediction"},{"title3":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond"},{"title3":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers"},{"title3":"Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study"},{"title3":"Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the Atherogene Study"},{"title3":"Atherosclerosis: an inflammatory disease"},{"title3":"Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions"},{"title3":"GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice"},{"title3":"Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study"},{"title3":"Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome"},{"title3":"Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study"},{"title3":"A sensitive cardiac troponin T assay in stable coronary artery disease"}]},{"title2":"Hospitalization and mortality among Black patients and White patients with COVID-19.","References":[{"title3":"COVID-19: cases in the US. Atlanta: Centers for Disease Control and Prevention, 2020 ()."},{"title3":"Characteristics of and important lessons from the coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy."},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 : United States, February 12-March 28, 2020."},{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) : United States, February 12-March 16, 2020."},{"title3":"Geographic differences in COVID-19 cases, deaths, and incidence : United States, February 12-April 7, 2020."},{"title3":". COVID-19 home page ()."},{"title3":". QuickFacts: Louisiana ()."},{"title3":". Facts &amp; statistics ()."},{"title3":". Uniform Data System Mapper ()."},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation."},{"title3":"How to measure comorbidity: a critical review of available methods."},{"title3":"Association of patient social, cognitive, and functional risk factors with preventable hospitalizations: implications for physician value-based payment."},{"title3":"Impact of overweight and obesity on hospitalization: race and gender differences."},{"title3":"Multiple imputation of discrete and continuous data by fully conditional specification."},{"title3":"Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis."},{"title3":"Characteristics and clinical outcomes of adult patients hospitalized with COVID-19 : Georgia, March 2020."},{"title3":". 2018 Louisiana health report card ()."},{"title3":"Covid-19 in critically ill patients in the Seattle region : case series."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area."},{"title3":"Genetic ancestry and natural selection drive population differences in immune responses to pathogens."},{"title3":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis."}]},{"title2":"GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells.","References":[{"title3":"Charac-terization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1)"},{"title3":"GDF-15/MIC-1 a novel member of the TGF-beta superfamily"},{"title3":"Nerve growth factor modulation of the cavernous nerve response to injury"},{"title3":"Induction of MIC-1/growth differentiation factor-15 following bile duct injury"},{"title3":"Growth differen-tiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury"},{"title3":"Growth differen-tiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms"},{"title3":"Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions"},{"title3":"Growth-differentiation factor-15 in heart failure"},{"title3":"The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide"},{"title3":"Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis"},{"title3":"Antiangi-ogenic activity of the MDM2 antagonist nutlin-3"},{"title3":"Macrophage inhibitory cytokine-1 regu-lates melanoma vascular development"},{"title3":"Updated clinical classification of pulmonary hypertension"},{"title3":"Cellular and molecular basis of pulmonary arterial hypertension"},{"title3":"Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion"},{"title3":"Molecular pathogenesis of pulmonary arterial hypertension"},{"title3":"Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension"},{"title3":"In-creased Expression of Growth Differentiation Factor-15 in Scleroderma-Associated Pulmonary Arterial Hypertension"},{"title3":"The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects"},{"title3":"PLAB, a novel placental bone mor-phogenetic protein"},{"title3":"Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells"},{"title3":"Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR"},{"title3":"Generation of human pulmonary microvascular endothelial cell lines"},{"title3":"Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus"},{"title3":"Response of micro- and macrovascular endothelial cells to starch-based fiber meshes for bone tissue engineering"},{"title3":"Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid x receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation"},{"title3":"Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress"},{"title3":"Hemodynamic shear stress and its role in atherosclero-sis"},{"title3":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays"},{"title3":"Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth"},{"title3":"Tensional forces in fibrillar extracellular matrices control directional capillary sprouting"},{"title3":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury"},{"title3":"Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay"},{"title3":"Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues"},{"title3":"Extracellular control of TGFbeta signalling in vascular develop-ment and disease"},{"title3":"Different distribution of plexiform lesions in primary and secondary pulmonary hypertension"},{"title3":"The pathobiology of pulmonary hypertension. Endothelium"},{"title3":"Antibodies against transforming growth fac-tor-beta 1 suppress intimal hyperplasia in a rat model"},{"title3":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension"},{"title3":"Molecular and cellular determinants of lung endothelial cell heterogene-ity"},{"title3":"Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis"}]},{"title2":"GDF-15 is elevated in children with mitochondrial diseases and is induced by mitochondrial dysfunction.","References":[{"title3":"GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction"}]},{"title2":"Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.","References":[]}]}]}